ARVN
Arvinas, Inc.NASDAQHealthcare$10.85-4.24%ClosedMarket Cap: $696.8M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
1.62
P/S
2.65
EV/EBITDA
-5.77
DCF Value
$-118.79
FCF Yield
-39.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
99.5%
Operating Margin
-44.0%
Net Margin
-30.8%
ROE
-14.3%
ROA
-11.3%
ROIC
-20.0%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $9.5M | 87.4% | $-71.7M | $-67.4M | $-1.04 | — |
| FY 2025 | $262.6M | 98.0% | $-114.9M | $-80.8M | $-1.28 | — |
| Q3 2025 | $41.9M | 100.0% | $-43.8M | $-35.1M | $-0.48 | — |
| Q2 2025 | $22.4M | 100.0% | $-71.5M | $-61.2M | $-0.84 | — |
| Q1 2025 | $188.8M | 100.0% | $71.4M | $82.9M | $1.14 | — |
| Q4 2024 | $59.2M | 100.0% | $-58.2M | $-45.1M | $-0.63 | — |
| FY 2024 | $263.4M | 100.0% | $-250.2M | $-198.9M | $-2.77 | — |
| Q3 2024 | $102.4M | 100.0% | $-60.3M | $-49.2M | $-0.68 | — |
| Q2 2024 | $76.5M | 97.8% | $-48.5M | $-35.2M | $-0.49 | — |
| Q1 2024 | $25.3M | 93.3% | $-83.3M | $-69.4M | $-0.97 | — |
| Q4 2023 | $-43.1M | 103.9% | $-165.3M | $-154.8M | $-2.53 | — |
| FY 2023 | $78.5M | 100.0% | $-401.5M | $-367.3M | $-6.62 | — |